EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma

Jiaye Lao, Ziqing Han, Xinjing Lou, Jinxuan Ye, Chen Gao iD, Linyu Wu

Thoracic Cancer · 2026

DOI: 10.1111/1759-7714.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2026. Verfasst von Jiaye Lao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Biomarkers, Tumor, Epithelial Cells. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Science and Technology Project of Zhejiang Province, Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project, the Research Project of Zhejiang Chinese Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Main Problem The treatment and prognosis of lung adenocarcinoma (LUAD) remain challenging. The study aimed to identify prognostic genes and construct a prognostic model for LUAD.

Methods

After identifying malignant alveolar type II (AT2) cells using InferCNV, we applied CytoTRACE, pseudo‐time analysis, Mendelian randomization (MR), and univariate Cox regression analysis to identify prognostic genes. A prognostic model was then developed using an optimized subset of these genes, selected through the least absolute shrinkage and selection operator (LASSO) algorithm. Further analyses included Gene Ontology enrichment analysis and the construction of a protein–protein interaction (PPI) network.

Results

Pseudo‐time analysis identified 3526 dynamically expressed genes during malignant AT2 cell dedifferentiation. Subsequent multi‐omics integration refined the gene selection, yielding four prognostic genes for the final predictive model. The resulting model achieved area under the receiver operating characteristic (ROC) curve (AUC) values of 0.649, 0.675, and 0.654 for predicting 1, 2, and 3‐year overall survival (OS) in the training set, respectively, and was successfully validated in two external cohorts at the corresponding time points. Moreover, survival analysis demonstrated that patients in the high‐risk group had significantly poorer OS than those in the low‐risk group, both in the training set and the validation sets ( p < 0.01).

Conclusions

The study developed a novel signature based on genes dynamically expressed during malignant AT2 cell dedifferentiation, capable of predicting the prognosis of LUAD patients, and offered four accurate prognostic biomarkers ( ADM , MARK4 , PARVA , and RPS6KA1 ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsBiomarkers, TumorEpithelial CellsHumansPrognosisGene Expression Regulation, NeoplasticGene Expression Profiling

Stichwörter der Autor:innen

Mendelian randomizationbulk RNA sequencinglung adenocarcinomaprognostic signaturesingle‐cell RNA sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.

ORCID-Profile: Chen Gao

Förderung

  • Medical and Health Science and Technology Project of Zhejiang Province
  • Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project
  • the Research Project of Zhejiang Chinese Medical University
  • Jinhua Public Welfare Technology Application Research Project
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Lao, J., Han, Z., Lou, X., Ye, J., Gao, C., & Wu, L. (2026). Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70244

Vancouver

Lao J, Han Z, Lou X, Ye J, Gao C, Wu L. Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma. Thoracic Cancer. 2026. doi:10.1111/1759-7714.70244

BibTeX
@article{Lao2026,
  author = {Lao, Jiaye and Han, Ziqing and Lou, Xinjing and Ye, Jinxuan and Gao, Chen and Wu, Linyu},
  title = {Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma},
  journal = {Thoracic Cancer},
  year = {2026},
  doi = {10.1111/1759-7714.70244}
}
Kostenlos starten →